Syndax Pharmaceuticals, Inc. ( SNDX) - Stock Earnings
SNDX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 2, 2026, midnight | — / — | — | — / — | — |
SNDX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -68.0 million USD | 68.5 million USD |
| 2026Q1 | -42.7 million USD | 64.9 million USD |
| 2026Q2 | -49.4 million USD | 72.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
SNDX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -209.4 million USD | — USD |
| 2024 | -318.8 million USD | 23.7 million USD |
| 2025 | -285.4 million USD | 172.4 million USD |
| 2026 Est. | — | — |
SNDX
Price: $13.65
52 week price:
Earnings Per Share: -2.51 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 44479
Ebitda: -15.3 millionMarket Capitalization: 1.6 billion